Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
McKesson
QuintilesIMS
Harvard Business School
Julphar
McKinsey
Express Scripts
Accenture

Generated: November 15, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072095

« Back to Dashboard

NDA 072095 describes TAB-PROFEN, which is a drug marketed by Perrigo and is included in one NDA. Additional details are available on the TAB-PROFEN profile page.

The generic ingredient in TAB-PROFEN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 072095
Tradename:TAB-PROFEN
Applicant:Perrigo
Ingredient:ibuprofen
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength200MG
Approval Date:Dec 8, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
AstraZeneca
Harvard Business School
Colorcon
US Department of Justice
Chinese Patent Office
Cerilliant
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.